Biobizkaia
Ikerketa zentroa
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoGlaxoSmithKline (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (11)
2024
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422
2023
2022
-
What are the prospects for antiplatelet agents for thromboprophylaxis in antiphospholipid syndrome?
Expert Review of Clinical Immunology
2021
-
Genetic mechanisms of critical illness in COVID-19
Nature, Vol. 591, Núm. 7848, pp. 92-98
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2018
-
Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain
European Journal of Pediatrics, Vol. 177, Núm. 2, pp. 181-192
2015
-
Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease
Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 1, Núm. 1, pp. 23-36
2013
2001
-
Effect of mode of administration on I-PSS scores in a large BPH patient population
European Urology, Vol. 40, Núm. 4, pp. 451-457
2000
-
Immunolocalization of the mGluR1b splice variant of the metabotropic glutamate receptor 1 at parallel fiber-Purkinje cell synapses in the rat cerebellar cortex
Journal of Neurochemistry, Vol. 74, Núm. 3, pp. 1301-1309